Pharma & Healthcare
Global Diagnostic Radiopharmaceuticals Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 436830
- Pages: 100
- Figures: 96
- Views: 2
The global Diagnostic Radiopharmaceuticals market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Technetium 99
Fluorine 18
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Cardiology
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Technetium 99 adoption vs. Fluorine 18 premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Cardiology potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Diagnostic Radiopharmaceuticals market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Fluorine 18 in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Technetium 99 dominance in Europe vs. Fluorine 18 demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
By Type: (Dominant Segment vs High-Margin Innovation)
Technetium 99
Fluorine 18
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Oncology
Cardiology
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Cardinal Health in Europe)
- Emerging Product Trends: Technetium 99 adoption vs. Fluorine 18 premiumization
- Demand-Side Dynamics: Oncology growth in China vs. Cardiology potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Diagnostic Radiopharmaceuticals market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Fluorine 18 in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Technetium 99 dominance in Europe vs. Fluorine 18 demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Diagnostic Radiopharmaceuticals Product Scope
1.2 Diagnostic Radiopharmaceuticals by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020 & 2024 & 2031)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts (2020-2031)
1.4.1 Global Diagnostic Radiopharmaceuticals Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Diagnostic Radiopharmaceuticals Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Diagnostic Radiopharmaceuticals Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
2.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
2.3 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.2 Europe Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.3 China Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.4 Japan Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Type (2020-2025)
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
3.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2020-2025)
3.1.3 Global Diagnostic Radiopharmaceuticals Price by Type (2020-2025)
3.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2026-2031)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2026-2031)
3.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2026-2031)
3.3 Different Types Diagnostic Radiopharmaceuticals Representative Players
4 Global Market Size by Application
4.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Application (2020-2025)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2025)
4.1.3 Global Diagnostic Radiopharmaceuticals Price by Application (2020-2025)
4.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2026-2031)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2026-2031)
4.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Diagnostic Radiopharmaceuticals Application
5 Competition Landscape by Players
5.1 Global Diagnostic Radiopharmaceuticals Sales by Players (2020-2025)
5.2 Global Top Diagnostic Radiopharmaceuticals Players by Revenue (2020-2025)
5.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2024)
5.4 Global Diagnostic Radiopharmaceuticals Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
5.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Diagnostic Radiopharmaceuticals Sales by Company
6.1.1.1 North America Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.1.1.2 North America Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.1.2 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.1.3 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.1.4 North America Diagnostic Radiopharmaceuticals Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Diagnostic Radiopharmaceuticals Sales by Company
6.2.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.2.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.2.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.2.3 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.2.4 Europe Diagnostic Radiopharmaceuticals Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Diagnostic Radiopharmaceuticals Sales by Company
6.3.1.1 China Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.3.1.2 China Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.3.2 China Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.3.3 China Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.3.4 China Diagnostic Radiopharmaceuticals Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Diagnostic Radiopharmaceuticals Sales by Company
6.4.1.1 Japan Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.4.1.2 Japan Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.4.2 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.4.3 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.4.4 Japan Diagnostic Radiopharmaceuticals Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Cardinal Health
7.1.1 Cardinal Health Company Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Information
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novartis Diagnostic Radiopharmaceuticals Products Offered
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Information
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Information
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.6.4 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Information
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Information
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
7.8.5 Bracco Imaging Recent Development
7.9 Eli Lilly
7.9.1 Eli Lilly Company Information
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
7.9.5 Eli Lilly Recent Development
7.10 China Isotope & Radiation
7.10.1 China Isotope & Radiation Company Information
7.10.2 China Isotope & Radiation Business Overview
7.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
7.10.5 China Isotope & Radiation Recent Development
7.11 Dongcheng
7.11.1 Dongcheng Company Information
7.11.2 Dongcheng Business Overview
7.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Dongcheng Diagnostic Radiopharmaceuticals Products Offered
7.11.5 Dongcheng Recent Development
8 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
8.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
8.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Diagnostic Radiopharmaceuticals Distributors List
9.3 Diagnostic Radiopharmaceuticals Customers
10 Diagnostic Radiopharmaceuticals Market Dynamics
10.1 Diagnostic Radiopharmaceuticals Industry Trends
10.2 Diagnostic Radiopharmaceuticals Market Drivers
10.3 Diagnostic Radiopharmaceuticals Market Challenges
10.4 Diagnostic Radiopharmaceuticals Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Diagnostic Radiopharmaceuticals Product Scope
1.2 Diagnostic Radiopharmaceuticals by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020 & 2024 & 2031)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts (2020-2031)
1.4.1 Global Diagnostic Radiopharmaceuticals Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Diagnostic Radiopharmaceuticals Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Diagnostic Radiopharmaceuticals Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
2.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
2.3 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.2 Europe Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.3 China Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
2.4.4 Japan Diagnostic Radiopharmaceuticals Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Type (2020-2025)
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2020-2025)
3.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2020-2025)
3.1.3 Global Diagnostic Radiopharmaceuticals Price by Type (2020-2025)
3.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2026-2031)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2026-2031)
3.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2026-2031)
3.3 Different Types Diagnostic Radiopharmaceuticals Representative Players
4 Global Market Size by Application
4.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Application (2020-2025)
4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2020-2025)
4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2020-2025)
4.1.3 Global Diagnostic Radiopharmaceuticals Price by Application (2020-2025)
4.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2026-2031)
4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2026-2031)
4.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Diagnostic Radiopharmaceuticals Application
5 Competition Landscape by Players
5.1 Global Diagnostic Radiopharmaceuticals Sales by Players (2020-2025)
5.2 Global Top Diagnostic Radiopharmaceuticals Players by Revenue (2020-2025)
5.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2024)
5.4 Global Diagnostic Radiopharmaceuticals Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
5.7 Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Diagnostic Radiopharmaceuticals Sales by Company
6.1.1.1 North America Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.1.1.2 North America Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.1.2 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.1.3 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.1.4 North America Diagnostic Radiopharmaceuticals Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Diagnostic Radiopharmaceuticals Sales by Company
6.2.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.2.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.2.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.2.3 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.2.4 Europe Diagnostic Radiopharmaceuticals Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Diagnostic Radiopharmaceuticals Sales by Company
6.3.1.1 China Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.3.1.2 China Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.3.2 China Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.3.3 China Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.3.4 China Diagnostic Radiopharmaceuticals Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Diagnostic Radiopharmaceuticals Sales by Company
6.4.1.1 Japan Diagnostic Radiopharmaceuticals Sales by Company (2020-2025)
6.4.1.2 Japan Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025)
6.4.2 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2020-2025)
6.4.3 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2020-2025)
6.4.4 Japan Diagnostic Radiopharmaceuticals Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Cardinal Health
7.1.1 Cardinal Health Company Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
7.1.5 Cardinal Health Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
7.2.5 GE Healthcare Recent Development
7.3 Jubilant Pharma
7.3.1 Jubilant Pharma Company Information
7.3.2 Jubilant Pharma Business Overview
7.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
7.3.5 Jubilant Pharma Recent Development
7.4 Novartis
7.4.1 Novartis Company Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novartis Diagnostic Radiopharmaceuticals Products Offered
7.4.5 Novartis Recent Development
7.5 Curium Pharma
7.5.1 Curium Pharma Company Information
7.5.2 Curium Pharma Business Overview
7.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
7.5.5 Curium Pharma Recent Development
7.6 SIEMENS
7.6.1 SIEMENS Company Information
7.6.2 SIEMENS Business Overview
7.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.6.4 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
7.6.5 SIEMENS Recent Development
7.7 Lantheus
7.7.1 Lantheus Company Information
7.7.2 Lantheus Business Overview
7.7.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
7.7.5 Lantheus Recent Development
7.8 Bracco Imaging
7.8.1 Bracco Imaging Company Information
7.8.2 Bracco Imaging Business Overview
7.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
7.8.5 Bracco Imaging Recent Development
7.9 Eli Lilly
7.9.1 Eli Lilly Company Information
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
7.9.5 Eli Lilly Recent Development
7.10 China Isotope & Radiation
7.10.1 China Isotope & Radiation Company Information
7.10.2 China Isotope & Radiation Business Overview
7.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
7.10.5 China Isotope & Radiation Recent Development
7.11 Dongcheng
7.11.1 Dongcheng Company Information
7.11.2 Dongcheng Business Overview
7.11.3 Dongcheng Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Dongcheng Diagnostic Radiopharmaceuticals Products Offered
7.11.5 Dongcheng Recent Development
8 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
8.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
8.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Diagnostic Radiopharmaceuticals Distributors List
9.3 Diagnostic Radiopharmaceuticals Customers
10 Diagnostic Radiopharmaceuticals Market Dynamics
10.1 Diagnostic Radiopharmaceuticals Industry Trends
10.2 Diagnostic Radiopharmaceuticals Market Drivers
10.3 Diagnostic Radiopharmaceuticals Market Challenges
10.4 Diagnostic Radiopharmaceuticals Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Diagnostic Radiopharmaceuticals Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Region (2020-2025)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Share by Region (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Sales (K Dose) Forecast by Region (2026-2031)
Table 9. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Diagnostic Radiopharmaceuticals Revenue Share Forecast by Region (2026-2031)
Table 12. Global Diagnostic Radiopharmaceuticals Sales by Type (K Dose) & (2020-2025)
Table 13. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2020-2025)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Diagnostic Radiopharmaceuticals Price by Type (US$/Dose) & (2020-2025)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Type (K Dose) & (2026-2031)
Table 17. Global Diagnostic Radiopharmaceuticals Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Diagnostic Radiopharmaceuticals Price by Type (US$/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Diagnostic Radiopharmaceuticals Sales by Application (K Dose) & (2020-2025)
Table 21. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2020-2025)
Table 22. Global Diagnostic Radiopharmaceuticals Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Diagnostic Radiopharmaceuticals Price by Application (US$/Dose) & (2020-2025)
Table 24. Global Diagnostic Radiopharmaceuticals Sales by Application (K Dose) & (2026-2031)
Table 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Diagnostic Radiopharmaceuticals Price by Application (US$/Dose) & (2026-2031)
Table 27. New Sources of Growth in Diagnostic Radiopharmaceuticals Application
Table 28. Global Diagnostic Radiopharmaceuticals Sales by Company (K Dose) & (2020-2025)
Table 29. Global Diagnostic Radiopharmaceuticals Sales Share by Company (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2024)
Table 33. Global Market Diagnostic Radiopharmaceuticals Average Price by Company (US$/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
Table 36. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 39. North America Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 40. North America Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 42. North America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 43. North America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 44. North America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 45. North America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 47. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 48. Europe Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 50. Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 51. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 52. Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 53. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 54. China Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 55. China Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 56. China Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 58. China Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 59. China Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 60. China Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 61. China Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 62. Japan Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 63. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 64. Japan Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 66. Japan Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 67. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 68. Japan Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 69. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 74. Cardinal Health Recent Development
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 79. GE Healthcare Recent Development
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 84. Jubilant Pharma Recent Development
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Novartis Diagnostic Radiopharmaceuticals Product
Table 89. Novartis Recent Development
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 94. Curium Pharma Recent Development
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 99. SIEMENS Recent Development
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Lantheus Diagnostic Radiopharmaceuticals Product
Table 104. Lantheus Recent Development
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 109. Bracco Imaging Recent Development
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 114. Eli Lilly Recent Development
Table 115. China Isotope & Radiation Company Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 119. China Isotope & Radiation Recent Development
Table 120. Dongcheng Company Information
Table 121. Dongcheng Description and Business Overview
Table 122. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Dongcheng Diagnostic Radiopharmaceuticals Product
Table 124. Dongcheng Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Diagnostic Radiopharmaceuticals Distributors List
Table 128. Diagnostic Radiopharmaceuticals Customers List
Table 129. Diagnostic Radiopharmaceuticals Market Trends
Table 130. Diagnostic Radiopharmaceuticals Market Drivers
Table 131. Diagnostic Radiopharmaceuticals Market Challenges
Table 132. Diagnostic Radiopharmaceuticals Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2024 & 2031
Figure 4. Technetium 99 Product Picture
Figure 5. Fluorine 18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2024 & 2031
Figure 9. Oncology Examples
Figure 10. Cardiology Examples
Figure 11. Other Examples
Figure 12. Global Diagnostic Radiopharmaceuticals Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Diagnostic Radiopharmaceuticals Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 15. Global Diagnostic Radiopharmaceuticals Price Trends Growth Rate (2020-2031) & (US$/Dose)
Figure 16. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 17. Global Market Diagnostic Radiopharmaceuticals Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 21. Europe Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 23. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 25. Japan Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2020-2025)
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2026-2031)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2026-2031)
Figure 30. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2020-2025)
Figure 31. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2026-2031)
Figure 33. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2026-2031)
Figure 34. Global Diagnostic Radiopharmaceuticals Sales Share by Company (2024)
Figure 35. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2024)
Figure 36. Global 5 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue in Diagnostic Radiopharmaceuticals: 2020 & 2024
Figure 37. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 39. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 40. Diagnostic Radiopharmaceuticals Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Table 1. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Diagnostic Radiopharmaceuticals Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Diagnostic Radiopharmaceuticals Sales (K Dose) by Region (2020-2025)
Table 5. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 6. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue Share by Region (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Sales (K Dose) Forecast by Region (2026-2031)
Table 9. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Diagnostic Radiopharmaceuticals Revenue Share Forecast by Region (2026-2031)
Table 12. Global Diagnostic Radiopharmaceuticals Sales by Type (K Dose) & (2020-2025)
Table 13. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2020-2025)
Table 14. Global Diagnostic Radiopharmaceuticals Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Diagnostic Radiopharmaceuticals Price by Type (US$/Dose) & (2020-2025)
Table 16. Global Diagnostic Radiopharmaceuticals Sales by Type (K Dose) & (2026-2031)
Table 17. Global Diagnostic Radiopharmaceuticals Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Diagnostic Radiopharmaceuticals Price by Type (US$/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Diagnostic Radiopharmaceuticals Sales by Application (K Dose) & (2020-2025)
Table 21. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2020-2025)
Table 22. Global Diagnostic Radiopharmaceuticals Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Diagnostic Radiopharmaceuticals Price by Application (US$/Dose) & (2020-2025)
Table 24. Global Diagnostic Radiopharmaceuticals Sales by Application (K Dose) & (2026-2031)
Table 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Diagnostic Radiopharmaceuticals Price by Application (US$/Dose) & (2026-2031)
Table 27. New Sources of Growth in Diagnostic Radiopharmaceuticals Application
Table 28. Global Diagnostic Radiopharmaceuticals Sales by Company (K Dose) & (2020-2025)
Table 29. Global Diagnostic Radiopharmaceuticals Sales Share by Company (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2024)
Table 33. Global Market Diagnostic Radiopharmaceuticals Average Price by Company (US$/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Product Type & Application
Table 36. Global Key Manufacturers of Diagnostic Radiopharmaceuticals, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 39. North America Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 40. North America Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 42. North America Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 43. North America Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 44. North America Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 45. North America Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 47. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 48. Europe Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 50. Europe Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 51. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 52. Europe Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 53. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 54. China Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 55. China Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 56. China Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 58. China Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 59. China Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 60. China Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 61. China Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 62. Japan Diagnostic Radiopharmaceuticals Sales by Company (2020-2025) & (K Dose)
Table 63. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 64. Japan Diagnostic Radiopharmaceuticals Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 66. Japan Diagnostic Radiopharmaceuticals Sales by Type (2020-2025) & (K Dose)
Table 67. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 68. Japan Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K Dose)
Table 69. Japan Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Cardinal Health Diagnostic Radiopharmaceuticals Product
Table 74. Cardinal Health Recent Development
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. GE Healthcare Diagnostic Radiopharmaceuticals Product
Table 79. GE Healthcare Recent Development
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Jubilant Pharma Diagnostic Radiopharmaceuticals Product
Table 84. Jubilant Pharma Recent Development
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Novartis Diagnostic Radiopharmaceuticals Product
Table 89. Novartis Recent Development
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Curium Pharma Diagnostic Radiopharmaceuticals Product
Table 94. Curium Pharma Recent Development
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. SIEMENS Diagnostic Radiopharmaceuticals Product
Table 99. SIEMENS Recent Development
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Lantheus Diagnostic Radiopharmaceuticals Product
Table 104. Lantheus Recent Development
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Bracco Imaging Diagnostic Radiopharmaceuticals Product
Table 109. Bracco Imaging Recent Development
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Eli Lilly Diagnostic Radiopharmaceuticals Product
Table 114. Eli Lilly Recent Development
Table 115. China Isotope & Radiation Company Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product
Table 119. China Isotope & Radiation Recent Development
Table 120. Dongcheng Company Information
Table 121. Dongcheng Description and Business Overview
Table 122. Dongcheng Diagnostic Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Dongcheng Diagnostic Radiopharmaceuticals Product
Table 124. Dongcheng Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Diagnostic Radiopharmaceuticals Distributors List
Table 128. Diagnostic Radiopharmaceuticals Customers List
Table 129. Diagnostic Radiopharmaceuticals Market Trends
Table 130. Diagnostic Radiopharmaceuticals Market Drivers
Table 131. Diagnostic Radiopharmaceuticals Market Challenges
Table 132. Diagnostic Radiopharmaceuticals Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals Product Picture
Figure 2. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2024 & 2031
Figure 4. Technetium 99 Product Picture
Figure 5. Fluorine 18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Radiopharmaceuticals Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2024 & 2031
Figure 9. Oncology Examples
Figure 10. Cardiology Examples
Figure 11. Other Examples
Figure 12. Global Diagnostic Radiopharmaceuticals Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Diagnostic Radiopharmaceuticals Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 15. Global Diagnostic Radiopharmaceuticals Price Trends Growth Rate (2020-2031) & (US$/Dose)
Figure 16. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 17. Global Market Diagnostic Radiopharmaceuticals Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 21. Europe Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 23. China Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 25. Japan Diagnostic Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Diagnostic Radiopharmaceuticals Sales (K Dose) Growth Rate (2020-2031)
Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2020-2025)
Figure 28. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2026-2031)
Figure 29. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2026-2031)
Figure 30. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2020-2025)
Figure 31. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Diagnostic Radiopharmaceuticals Sales Share by Application (2026-2031)
Figure 33. Global Diagnostic Radiopharmaceuticals Revenue Share by Application (2026-2031)
Figure 34. Global Diagnostic Radiopharmaceuticals Sales Share by Company (2024)
Figure 35. Global Diagnostic Radiopharmaceuticals Revenue Share by Company (2024)
Figure 36. Global 5 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue in Diagnostic Radiopharmaceuticals: 2020 & 2024
Figure 37. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 39. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 40. Diagnostic Radiopharmaceuticals Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232